NASDAQ: TNFATnf Pharmaceuticals Inc Stock Ownership - Who owns Tnf Pharmaceuticals?
Insider buying vs selling
Have Tnf Pharmaceuticals Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when TNFA insiders and whales buy or sell their stock.
TNFA Shareholders
What type of owners hold Tnf Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Caroline C. Williams | 284.09% | 5,017,423 | $20.27M | Insider |
| Thomas J. Knox | 27.07% | 478,150 | $1.93M | Insider |
| Paul Rivard | 22.65% | 400,000 | $1.62M | Insider |
| Hudson Bay Capital Management LP | 13.61% | 240,305 | $970.83k | Insider |
| Raymond Francis Akers Jr. | 12.01% | 212,100 | $856.88k | Insider |
| Morgan Stanley | 10.87% | 192,035 | $775.82k | Institution |
| John J. Gormally | 10.19% | 180,000 | $727.20k | Insider |
| Brandon Thomas Knox | 7.04% | 124,326 | $502.28k | Insider |
| Christopher C. Chapman Jr. | 5.46% | 96,475 | $389.76k | Insider |
| Joshua Silverman | 5.03% | 88,775 | $358.65k | Insider |
TNFA vs Biotech Stocks
Tnf Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.